Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,073 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue?
Angra P, Becx-Bleumink M, Gilpin C, Joloba M, Jost K, Kam KM, Kim SJ, Lumb R, Mitarai S, Ramsay A, Ridderhof J, Rieder HL, Selvakumar N, van Beers S, van Cleeff M, Van Deun A, Vincent V. Angra P, et al. Among authors: kim sj. Int J Tuberc Lung Dis. 2007 Nov;11(11):1160-1. Int J Tuberc Lung Dis. 2007. PMID: 17958975 No abstract available.
Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
Aït-Khaled N, Alarcon E, Bissell K, Boillot F, Caminero JA, Chiang CY, Clevenbergh P, Dlodlo R, Enarson DA, Enarson P, Ferroussier O, Fujiwara PI, Harries AD, Heldal E, Hinderaker SG, Kim SJ, Lienhardt C, Rieder HL, Rusen ID, Trébucq A, Van Deun A, Wilson N. Aït-Khaled N, et al. Among authors: kim sj. Int J Tuberc Lung Dis. 2009 Aug;13(8):927-35. Int J Tuberc Lung Dis. 2009. PMID: 19723371
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P. Pablos-Méndez A, et al. Among authors: kim sj. N Engl J Med. 1998 Jun 4;338(23):1641-9. doi: 10.1056/NEJM199806043382301. N Engl J Med. 1998. PMID: 9614254 Free article.
Is second-line anti-tuberculosis drug susceptibility testing reliable?
Kim SJ, Espinal MA, Abe C, Bai GH, Boulahbal F, Fattorin L, Gilpin C, Hoffner S, Kam KM, Martin-Casabona N, Rigouts L, Vincent V. Kim SJ, et al. Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8. Int J Tuberc Lung Dis. 2004. PMID: 15455606 No abstract available.
Measuring tuberculosis burden, trends, and the impact of control programmes.
Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, Gopi PG, Hosseini M, Kim SJ, Manissero D, Onozaki I, Rieder HL, Scheele S, van Leth F, van der Werf M, Williams BG. Dye C, et al. Among authors: kim sj. Lancet Infect Dis. 2008 Apr;8(4):233-43. doi: 10.1016/S1473-3099(07)70291-8. Epub 2008 Jan 16. Lancet Infect Dis. 2008. PMID: 18201929 Review.
14,073 results
You have reached the last available page of results. Please see the User Guide for more information.